USPTO serial 79372993
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mark Lerner, Esq.
Mark Lerner, Esq. DUANE MORRIS LLP230 Park Avenue, Suite 1130New York, NY 10169United States| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical and bio-chemical products, preparations and substances for life science research and for use in biochemistry, clinical chemistry and microbiology; chemical reagents other than for medical or veterinary purposes; chemical reagents for laboratory use, other than for medical or veterinary purposes; chemical test reagents, other than for medical or veterinary purposes; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; diagnostic reagents and buffers for scientific use; reagent kits comprising generic DNA circle, DNA primers polymerase and buffers for use in biotechnology fields; chemical preparations and substances for use in scientific analysis and research; chemical preparations and substances for biological and genetic research; biochemical products used in science and in laboratory analysis, namely, receptors, nuclear receptors; receptor agonists and receptor anti-agonists; chemogenetic preparations and substances, namely protein receptors used in science and laboratory analysis; ion channel inhibitors for use in the manufacture of pharmaceuticals and drugs; proteins for use in scientific research and analysis relating to genetic diseases; peptides and amino acids for laboratory or research use; in-vivo photo pharmacology diagnostic preparations and substances for laboratory or research use; fluorescent dyes, chemically activated adhesive labels and stains for chemical, bio-chemical and molecular analysis; enzymes and enzymatic preparations and substances for scientific purposes; stem cells other than for medical or veterinary purposes | ACTIVE | — |
| 005 | Chemical reagents for medical or veterinary purposes; medical diagnostic reagent kits composed of chemical and biological reagents for the treatment, monitoring and diagnosis of disease for medical purposes; molecular test and testing reagents for medical use; in-vivo diagnostic reagents for medical use; laboratory reagents for medical or veterinary use; reagents for laboratory testing for medical or veterinary use; chemical diagnostic reagents for medical or veterinary use; chemical reagents for medical use in the field of life science research and for use in biochemistry, clinical chemistry and microbiology and preparations for medical analysis; biological reagents for medical use in the field of life science research and for use in biochemistry, clinical chemistry and microbiology and preparations for medical analysis; colostral antibodies for medical purposes; chemical products and preparations for use in radio chemical analysis for medical purposes; biochemical preparations and substances for medical, diagnostic or pharmaceutical use; Protein arrays for medical diagnostic purposes; peptides and amino acid preparations for medical purposes; in-vitro photo pharmacology diagnostic preparations and substances for medical use; antibiotics; diagnostic reagents and buffers for medical use; injectable medical dyes and stains for chemical, bio-chemical or molecular analysis for medical diagnostic purposes; enzymes and enzymatic preparations and substances for medical purposes; stem cells for medical or veterinary purposes; pharmaceutical preparations, namely therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders; DNA vaccines; antivirals for pharmaceutical or medical purposes | ACTIVE | — |
| 009 | electronic imaging apparatus in the field of iridology not for medical purposes; DNA chips; downloadable software for use in delivering content in the field of biochemistry, clinical chemistry and microbiology; downloadable medical and scientific software for use in delivering content in the field of biochemistry, clinical chemistry and microbiology; downloadable computer software applications for mobile phones, handheld computers, namely applications for use in delivering content in the field of biochemistry, clinical chemistry and microbiology; downloadable electronic publications, namely, books, magazines, brochures about life sciences for use by medical professionals in the field of science and medicine; downloadable scientific materials, namely, scientific papers, articles; downloadable educational and teaching material in the field of biochemistry, clinical chemistry and microbiology | ACTIVE | — |
| 041 | Education and training services, namely, conducting programs in the field of science, chemistry, biology, biochemistry or life science and the distribution of course materials, namely, scientific, chemical, biological, biochemical or life science papers and publications, guides, and calculators for scientific education and training in connection therewith; non-downloadable electronic publications, namely books, magazines, brochures about life sciences for use by medical professionals in the field of science and medicine; online non-downloadable publications, namely scientific, chemical, biological biochemical or life science papers and publications; arranging and conducting of conferences, seminars and exhibitions in the field of biochemistry, clinical chemistry and microbiology and the distribution of course materials, namely, scientific, chemical, biological, biochemical or life science papers and publications, guides, and calculators for scientific education and training in connection therewith; advisory and consultancy services in connection with all of the aforesaid services | ACTIVE | — |
| 042 | Advisory and consultancy services relating to scientific research and development; chemical, pharmacology, biological and biochemical research and development services; laboratory research and development services in connection with chemistry, pharmacology, biology, and biochemistry; pharmaceutical research and development services; chemical, biological and biochemical analysis services; molecular biology and genetic research services; chemical, scientific, biological and biochemical research advisory and consultancy services; the provision of tools and printed guides for use in scientific, biological and biochemical research and development and advisory and consultancy services in connection with all of the aforesaid services | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 12, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 27, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 27, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 11, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 28, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Feb 11, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Feb 11, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 10, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 9, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Dec 24, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 24, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 18, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 18, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 30, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 30, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 30, 2024 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Apr 4, 2024 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 4, 2024 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 4, 2024 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 23, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 20, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 20, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 20, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 26, 2023 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Sep 25, 2023 | CREV | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED | — |
| Sep 13, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 10, 2023 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Aug 17, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 17, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 18, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 17, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 7, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 3, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 3, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 29, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |